Neuro-Oncology Reviews

Volume 26 Number 28
10 December 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 28, 10 December

Mondia MWL, Alonto AHD, Pang NGT, Resma FML, Molina AJR, Gacula JKV, Pauco AE, Chua AE, Batara JMF.
Thallium-201 single photon emission computed tomography for the differentiation of malignant versus non-malignant intracranial space-occupying lesions in developing countries.
Curr Probl Cancer. 2024 Dec 2;54:101160. doi: 10.1016/j.currproblcancer.2024.101160. PMID: 39626358. Review˰ ˍ

Elguindy MM, Young JS, Ho WS, Lu RO.
Co-evolution of glioma and immune microenvironment.
J Immunother Cancer. 2024 Dec 3;12(12):e009175. doi: 10.1136/jitc-2024-009175. PMID: 39631850. Review. ˍ

Palmieri M, Capobianco M, Demichele G, Bari-Bruno GD, Iovannitti G, Giordano B, Corsini M, Santoro A, Salvati M, Frati A, Pesce A.
Clinical and functional outcome for gliomas located in the primary and supplementary motor area. Surgical series and systematic Literature review.
J Clin Neurosci. 2024 Dec 3;132:110938? doi: 10.1016/j.jocn.2024.110938? PMID: 39631114. Observational study; Review˰ ˍ

Pinto-Fraga J, García-Chico C, Lista S, Lacal PM, Carpenzano G, Salvati M, Santos-Lozano A, Graziani G, Ceci C.
protein kinase inhibitors as Targeted therapy for glioblastoma: A meta-analysis of randomized controlled clinical trials.
Pharmacol Res? 2024 Dec 3:107528. doi: 10.1016/j.phrs.2024.107528? PMID: 39637954. Review˰ ˍ

Rossi J, Cavallieri F, Bassi MC, Venturelli F, Toschi G, Di Rauso G, Lucchi C, Donati B, Rizzi R, Russo M, Bondavalli M, Iaccarino C, Pavesi G, Neri A, Biagini G, Ciarrocchi A, Rossi PG, Pisanello A, Valzania F.
To be or not to be: The dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma - a systematic review and meta-analysis.
BMC Cancer. 2024 Dec 3;24(1):1488. doi: 10.1186/s12885-024-13249-8. PMID: 39627753. Review; Meta-analysis. ˍ

Still MEH, Moor RSF, Ghiaseddin AP, Leibetseder A, Hottinger AF, Berghoff A, Leung D.
How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma?
Neurooncol Pract. 2024 Dec 3;12(Suppl 1):i19-i25. doi: 10.1093/nop/npae112. PMID: 39776526. Review. ˍ

Liu Q, Hu M, Li S, Zhang X, Zhang R, Lyu H, Xiao S, Guo D, Chen XZ, Tang J, Zhou C.
TRPM channels in human cancers: regulatory mechanism and therapeutic prospects.
Biomark Res. 2024 Dec 4;12(1):152. doi: 10.1186/s40364-024-00699-2. PMID: 39633507. Review. ˍ

Hoang H, Mellal A, Dulloo M, Nguyen RT, Al-Saidi NN, Magableh H, Cailleteau A, Ghaith AK, El-Hajj VG, Elmi-Terander A.
Determining the Predictors of Recurrence or Regrowth Following Spinal Astrocytoma Resection: A Systematic Review and Meta-Analysis.
Brain Sci. 2024 Dec 4;14(12):1226. doi: 10.3390/brainsci14121226. PMID: 39766425. Review; Meta-Analysis. ˍ

Malmström A, Oppong FB, O Callaghan CJ, Wick W, Laperriere N, Gorlia T, Weller M, Henriksson R, Mason W, Platten M, Cantagallo E, Grønberg BH, Reifenberger G, Marosi C, Perry JR; NCBTSG, NOA, CCTG and EORTC Brain Tumor Group.
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.
Neurooncol Adv. 2024 Dec 4;6(1):vdae211. doi: 10.1093/noajnl/vdae211. PMID: 39759261. Pooled analysis. ˍ

Power P, Straehla JP, Fangusaro J, Bandopadhayay P, Manoharan N.
Pediatric neuro-oncology: Highlights of the last quarter-century.
Neoplasia. 2024 Dec 4;59:101098. doi: 10.1016/j.neo.2024.101098. PMID: 39637686. Review. ˍ

Roth P, Capper D, Calabrese E, Halasz LM, Jakola AS.
Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.
Neurooncol Pract. 2024 Dec 4;12(Suppl 1):i29-i37. doi: 10.1093/nop/npae100. PMID: 39776528. Review. ˍ

Chen L, Zhang H, Shang C, Hong Y.
The Role and Applied Value of Mitochondria in Glioma-Related Research.
CNS Neurosci Ther. 2024 Dec 5;30(12):e70121. doi: 10.1111/cns.70121. PMID: 39639571. Review. ˍ

He C, Xiong P, Zeng C, Qiu X, Long T, Song H.
Bibliometric analysis of the top 100 most cited articles on the immunotherapy for glioblastoma.
Childs Nerv Syst. 2024 Dec 5;41(1):33. doi: 10.1007/s00381-024-06693-1. PMID: 39633087. Bibliometric analysis˰ ˍ

Motamed-Sanaye A, Mortezaei A, Afshari AR, Saadatian Z, Faraji AH, Sheehan JP, Mokhtari AM.
Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.
J Neurooncol. 2024 Dec 5. doi: 10.1007/s11060-024-04865-2. PMID: 39636552. Meta-analysis˰ ˍ

Nayak SS, Pendem S, Menon GR, Sampathila N, Koteshwar P.
Quality Assessment of MRI-Radiomics-Based Machine Learning Methods in Classification of Brain Tumors: Systematic Review.
Diagnostics (Basel). 2024 Dec 5;14(23):2741. doi: 10.3390/diagnostics14232741. PMID: 39682649. Review. ˍ

Whitby A, Dandapani M.
Monitoring central nervous system tumour metabolism using cerebrospinal fluid.
Front Oncol. 2024 Dec 5;14:1389529. doi: 10.3389/fonc.2024.1389529. PMID: 39703845. Review. ˍ

Georgiannakis A, Chapman CAR, Paraskevopoulos D.
Surgical identification of brain tumour margins through impedance monitoring and electrocorticography and the potential for their combined use: A systematic review.
Neurosurg Rev. 2024 Dec 6;47(1):888. doi: 10.1007/s10143-024-03134-0. PMID: 39638915. Review. ˍ

Wach J, Vychopen M, Basaran AE, Güresir A, Seidel C, Kühnapfel A, Güresir E.
Efficacy and safety of intraoperative MRI in glioma surgery: a systematic review and meta-analysis of prospective randomized controlled trials.
J Neurosurg. 2024 Dec 6:1-12. doi: 10.3171/2024.7.JNS241102. PMID: 39642374. Review; Meta-analysis˰ ˍ

Wahid MA, Khan MT, Hussain JM, Malik H, Umar SA, Mughal S, Hasanain M, Anjum MU, Mahmmoud Fadelallah Eljack M.
Emerging paradigm: Molecularly targeted therapy with Dabrafenib and Trametinib in recurring pediatric gliomas with BRAF mutations: A narrative review.
Medicine (Baltimore). 2024 Dec 6;103(49):e40735. doi: 10.1097/MD.0000000000040735. PMID: 39654184. Review. ˍ

Gerritsen JKW, Karschnia P, Young JS, van den Bent MJ, Chang SM, Smith TR, Nahed BV, Rincon-Torroella J, Bettegowda C, Sanai N, Krieg SM, Maruyama T, Schucht P, Broekman MLD, Tonn JC, Wen PY, De Vleeschouwer S, Vincent AJPE, Hervey-Jumper S, Berger MS, Mekary RA, Molinaro AM.
Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER Consortium.
Neuro Oncol. 2024 Dec 7:noae261. doi: 10.1093/neuonc/noae261. PMID: 39657588. Review; Practical guide. ˍ

Tang K, Cesaire M, McDonald T, Cimino PJ, Castro MG, Jackson S.
A scoping review of diffuse hemispheric glioma, H3 G34-mutant: Epigenetic and molecular profiles, clinicopathology, and treatment avenues.
Neurooncol Adv. 2024 Dec 7;6(1):vdae208. doi: 10.1093/noajnl/vdae208. PMID: 39759262. Review. ˍ

Cozzi FM, Mayrand RC, Wan Y, Price SJ.
Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review.
J Neuroimaging. 2024 Dec 9;35(1):e13251. doi: 10.1111/jon.13251. PMID: 39648937. Review. ˍ

Mesas C, Moreno J, Doello K, Peña M, López-Romero JM, Prados J, Melguizo C.
Cannabidiol effects in stem cells: A systematic review.
Biofactors. 2024 Dec 9. doi: 10.1002/biof.2148. PMID: 39653426. Review. ˍ

Vethe Hernes I, Jansdatter A, Nordsteien A, Haraldsen Normann M.
Illuminating the hidden cost: A systematic review of cognitive late effects regarding cancer-related fatigue in treated paediatric brain tumors.
Tech Innov Patient Support Radiat Oncol. 2024 Dec 9;33:100291. doi: 10.1016/j.tipsro.2024.100291. PMID: 39759484. Review. ˍ

Vychopen M, Güresir A, Basaran AE, Güresir E, Wach J.
Impact of levetiracetam use in glioblastoma: an individual patient-level meta-analysis assessing overall survival.
Neurosurg Rev. 2024 Dec 9;47(1):897. doi: 10.1007/s10143-024-03137-x. PMID: 39653818. Meta-analysis. ˍ

Chassé M, Vasdev N.
PET in neurotherapeutic discovery and development.
Neurotherapeutics. 2024 Dec 10:e00498. doi: 10.1016/j.neurot.2024.e00498. PMID: 39665954. Perspective. ˍ

Harbi E, Aschner M.
Role of BRCA1 in glioblastoma etiology.
Cell Oncol (Dordr). 2024 Dec 10. doi: 10.1007/s13402-024-01024-7. PMID: 39656422. Review˰ ˍ

Shiroishi MS, Erickson BJ, Hu LS, Barboriak DP, Becerra L, Bell LC, Boss MA, Boxerman JL, Cen S, Cimino L, Fan Z, Keenan KE, Kirsch JE, Ameli N, Nazemi S, Quarles CC, Rosen MA, Rodriguez L, Schmainda KM, Zahlmann G, Zhou Y, Obuchowski N, Wu O; RSNA QIBA Dynamic Susceptibility Contrast MRI Biomarker Committee.
The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas.
Radiology. 2024 Dec 10;313(3):e232555. doi: 10.1148/radiol.232555. PMID: 39656118. Review˰ ˍ